This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.
Tysabri Progressive Multifocal Leukoencephalopathy claim valuation factors overview
A focused review of background, context, and source material on this subject.
Reference: Centers for Disease Control and Prevention (CDC)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: National Institutes of Health (NIH)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: European Medicines Agency (EMA)
Authoritative source for clinical, regulatory, and public-health background reading.